GCase targeting therapeutic (Congruence Therapeutics)

N/A

Report date: 2025/06/11 10:49:37
NME

Base Information

Drug NameGCase targeting therapeutic (Congruence Therapeutics)
Drug Alias NameN/A
ClassificationSmall molecules
Mechanisms of ActionGlucosylceramidase modulators
TargetsGlucosylceramidase
Therapy Area/IndicationsParkinson Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCongruence Therapeutics Inc
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsParkinson Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A